Clinical Trial: Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Latisse(Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo
Brief Summary: The primary purpose of this study is to assess efficacy and safety of Latisse (bimatoprost .03% ophthalmic solution) applied to the lateral and medial eyebrows. The primary outcome is a increase in overall eyebrow prominence as measured by at least a 1-grade increase on the Global Eyebrow Assessment (GEyA) scale, from baseline to the end of the treatment which will be day 270 period.
Detailed Summary:
Sponsor: Kenneth Beer
Current Primary Outcome: Efficacy of Latisse applied to the lateral and medial eyebrow [ Time Frame: 10 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Beer, Kenneth R., M.D., PA
Dates:
Date Received: July 1, 2011
Date Started: March 2011
Date Completion:
Last Updated: June 14, 2012
Last Verified: June 2012